Please provide your email address to receive an email when new articles are posted on . Micropulse transscleral cyclophotocoagulation lowered IOP in pediatric patients with refractory glaucoma, ...
MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (IRIX), headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the ...
Iridex Corporation announced the publication of a significant peer-reviewed study in Ophthalmology Therapy, demonstrating the long-term safety and efficacy of MicroPulse Transscleral Laser Therapy ...
MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results